Serial #97790928
LIVE

Serial Number

97790928

Owner

FORTREA INC.

Attorney

Laura C. Miller

First Use Date

Feb 9, 2023

Filing Date

Feb 11, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97790928 Trademark

Serial Number: 97790928 • Registration: 8188098

Serial #97790928 is a trademark filed by FORTREA INC. on February 11, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

FORTREA INC. (12 trademarks)

8 MOORE DRIVE
DURHAM, NC 27709

Entity Type: 03

Labcorp Drug Development Inc.

10 Moore Dr
Durham, NC 27703

Entity Type: 03

Trademark Details

Filing Date

February 11, 2023

Registration Date

March 24, 2026

First Use Anywhere

February 9, 2023

Published for Opposition

May 28, 2024

Goods & Services

Business consulting, management, and planning services in the field of clinical trials; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval and post-approval actions related to drugs and medical devices; economic forecasting and analysis in the field of pharmaceutical, biotechnology, and medical device industries; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business management services, namely, supply and demand forecasting in connection with drug supplies for clinical trials; recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients and volunteers for participation in clinical trials for the testing of drugs; business administration of patient reimbursement programs; business advisory services, business consultancy services, business data analysis, business information services, business management consulting, business strategy development services, market intelligence services, market research, marketing services, electronic data collection and data submission services for business purposes, database management, business project management services all in the fields of clinical trials and post approval pharmaceuticals, medical devices, and biotechnology; market research and business marketing consulting services in the fields of international health and pharmaceutical, biotechnology, and medical device industries; market analysis in the field of international health and in the pharmaceutical, biotechnology, and medical device industries; providing business and statistical information for business purposes and data processing services, all in the field of international health and in the pharmaceutical, biotechnology, and medical device industries

Pharmaceutical drug development services; design and testing of new products, namely, medical devices, for others; research and development in the fields of pharmaceuticals, medical devices, and biotechnology; medical and scientific research in the field of clinical trials, namely, designing, organizing, conducting, monitoring, and managing clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of design, planning, and implementation project management of clinical trials and studies on pharmaceuticals and medical devices; providing temporary use of online non-downloadable software for the collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; rental of laboratory apparatus and instruments; database design and development in the field of pharmaceutical drug development and medical device testing services; design and development of software for use in conducting research in pharmaceutical and medical device development studies; providing online computer databases in the fields of research and development of pharmaceuticals, medical devices, and biotechnology; data mining in the fields of research and development of pharmaceuticals, medical devices, and biotechnology; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical trials and studies on pharmaceuticals and medical devices; advisory services for others in the field of pharmaceutical drug development; providing medical and scientific research information in the fields of biochemistry, pharmaceuticals and clinical trials; providing online non-downloadable software for tracking, monitoring, analyzing, generating and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; application service provider (ASP) featuring software for use in database and record management in the fields of clinical trials and post-approval research for pharmaceuticals and medical devices; providing temporary use of online non downloadable software for collecting, organizing, and reporting clinical trial information and trial results; providing temporary use of online non-downloadable software for uploading and accessing test results in the field of medical testing for scientific research purposes; providing temporary use of online non-downloadable software for storing, retrieving, accessing, displaying, managing, analyzing, and reviewing information and data in the fields of pharmaceuticals, medical devices, and biotechnology; scientific study and research in the field of production of pharmaceuticals and medical devices; providing online non-downloadable software for planning, managing and supporting clinical trials; medical and scientific clinical research for others in the field of the production of pharmaceuticals, biopharmaceuticals, and medical devices; software as a service (SAAS) services, namely, hosting software for use by others for the collection, review, analysis, and reporting of clinical trial and drug development information; research and development in the field of pharmaceuticals, biopharmaceuticals, medical devices, and medical diagnostics; clinical research in the field of production of pharmaceuticals, medical devices and medical diagnostics; providing interactive web sites featuring technology that enables users to collect, review, analyze and report on clinical research and drug development information; providing temporary use of online non downloadable software to allow users to collect, review, analyze and report on clinical research and drug development

Medical services in the field of pharmacology and specimen collection and procedures in connection with clinical trials; providing an online computer database featuring medical information in the field of patient management and outcomes; providing a website featuring medical information in the fields of clinical trials and patient management and outcomes; medical and pharmaceutical consultation

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 3, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 3, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 2, 2026 SUPC
ITU LETTER MAILED, NO RESPONSE REQUIRED
Mar 2, 2026 IULN
SOU TEAS EXTENSION RECEIVED
Jan 23, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2025 EXRA
USE AMENDMENT FILED
Jul 23, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 23, 2025 EISU
SOU EXTENSION 2 GRANTED
Jul 23, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 23, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 23, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 23, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 23, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 23, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 23, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 19, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 19, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 19, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 19, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 19, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 14, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 14, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 14, 2023 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 9, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 9, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 9, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 2, 2023 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 7, 2023 ASGN
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 4, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 3, 2023 NWOS
NEW APPLICATION ENTERED
Feb 15, 2023 NWAP